MIMETAS

BiomimX

BiomimX develops organs-on-chip platforms that provide mechanical stimulation to 3D microtissues for drug and medical device testing by pharmaceutical and biotechnology companies.

MISO Chip

This company develops microfluidic tumor-on-a-chip platforms for biopharmaceutical firms and academic researchers to conduct preclinical ex vivo drug testing on human tissue models.

Finnadvance

This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.

VitrofluidiX

VitrofluidiX develops an integrated organ-on-a-chip platform for pharmaceutical companies and research institutions to conduct predictive human biology testing without animal models.

Hooke Bio

This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.

AIM Biotech

This company develops organ-on-a-chip microfluidic platforms and research services for pharmaceutical firms and academic researchers to conduct preclinical human-tissue drug testing.

Tissue Dynamics

This company develops sensor-integrated organ-on-chip platforms for pharmaceutical, nutraceutical and cosmetic customers to accelerate drug discovery and safety testing.

NETRI

NETRI develops organ-on-chip devices and AI algorithms for pharmaceutical and cosmetic companies to predict drug toxicity and efficacy using human cell models.